We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

September 22, 2010

Valeant International (Barbados) SRL v. Par Pharmaceutical Companies, Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. December 9, 2011

    Valeant Ends Fight With Par Over Generic Antidepressant

    A unit of Valeant Pharmaceuticals International Inc. on Thursday resolved its suit in New York federal court accusing Par Pharmaceutical Cos. Inc. of infringing its patents by seeking to launch a generic version of Valeant’s antidepressant Aplenzin.


Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!